AstraZeneca is continuing to study AZD8205 as a monotherapy in dose optimization expansion cohorts of patients with ...

Other researchers have also been studying mixing vaccine types to fight COVID-19. A Spanish study recently reported that people who initially received the AstraZeneca vaccine experienced a massive ...

If the trial design doesn't cause regulatory issues, the results could reshape how muscle-invasive bladder tumors are treated ...

finds bombshell new study into the origin of the global pandemic "This has led to a decline in demand for Vaxzevria, which is ...

AstraZeneca’s Phase 3 study in bladder cancer, showed that giving Imfinzi — before and after surgery — cut the risk of death.

A new SERD molecular entity, camizestrant, is under clinical development by biopharmaceutical company AstraZeneca and is currently in a Phase III study. The drug candidate is administered orally ...

The study, published in Nature Communications ... the wide uptake of future COVID-19 vaccination programs. In July, AstraZeneca declared a worldwide cessation of its COVID-19 vaccine, Vaxzevria ...

Giving people the tools to do their job more effectively has boosted productivity at AstraZeneca ... the benefits of this evolution in a case study video produced by Veeva. She said: “We ...

The Pfizer and AstraZeneca coronavirus vaccines are highly effective against the variant identified in India after two doses, a study has found. Two jabs of either vaccine give a similar level of ...

AstraZeneca (NASDAQ:AZN ... today at the European Society for Medical Oncology (ESMO) Congress 2024. The study, which examined the STRIDE regimen (Single Tremelimumab-actl Regular Interval ...

A second by-election loss in a second Liberal Party stronghold should have Canada’s Justin Trudeau questioning if any seat is safe. Canadians have been trying for a year to tell their Prime ...